PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Stoke Therapeutics, Inc. STOK (“Stoke”) on behalf of the company’s investors. Since July 2023, shares of Stoke’s common stock have declined in value from a trading price of over $10.00 per share to a current…Read More
SHAREHOLDER ALERT Kaskela Law LLC Announces Investigation of Stoke Therapeutics Inc NASDAQ STOK and Encourages Investors to Contact the Firm Stoke Therapeutics NASDAQSTOK
